Blueprint Medicines Corp (BPMC)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$87.46

Buy

$105.99

arrow-up$1.785 (+1.76%)

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include avapritinib, BLU 554, BLU-782 and BLU-667.

Prices updated at 20 May 2025, 23:14 EDT

| Prices minimum 15 mins delay

|

Prices in USD

NASDAQ

-0.38%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$103.15 - $96.15
	$121.90 - $73.04
	-
	6,536.68m
	-
	-
	448,916
	19.11
	777,594.29
	0.81
	63.71m
	US09627Y1091
	-2.51
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Investment accounts

Adult accounts

Child accounts

Choosing Fidelity

Financial advice & support

Fidelity’s Services

Guides

Guidance and tools

Funds

Choose your funds

Tools and information

Shares

Share dealing

Choose your shares

Tools and information

Pensions & retirement

Pensions, tax & tools

Saving for retirement

Approaching / In retirement